We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

109 hedge funds and large institutions have $165M invested in Surgalign Holdings, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 32 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

2% more funds holding

Funds holding: 107109 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 32

18% less capital invested

Capital invested by funds: $200M → $165M (-$35.1M)

Holders
109
Holders Change
+2
Holders Change %
+1.87%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
32
Reduced
32
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SIM
51
Spark Investment Management
New York
$303K
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
$301K +$107K +825 +44%
Goldman Sachs
53
Goldman Sachs
New York
$287K +$250K +1,920 +288%
Los Angeles Capital Management
54
Los Angeles Capital Management
California
$284K +$333K +2,559 New
AllianceBernstein
55
AllianceBernstein
Tennessee
$254K
Bank of America
56
Bank of America
North Carolina
$249K +$72.7K +558 +33%
MC
57
Menta Capital
California
$246K -$12.5K -96 -4%
TA
58
Teton Advisors
New York
$244K
Ameriprise
59
Ameriprise
Minnesota
$233K -$9.12K -70 -3%
CAM
60
ClariVest Asset Management
California
$209K -$49.2K -378 -17%
Axa
61
Axa
France
$204K +$240K +1,840 New
New York State Common Retirement Fund
62
New York State Common Retirement Fund
New York
$193K
SRAM
63
Stone Ridge Asset Management
New York
$171K +$6.12K +47 +3%
Manulife (Manufacturers Life Insurance)
64
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$151K -$18K -138 -9%
PP
65
PDT Partners
New York
$142K +$52.1K +400 +45%
AIG
66
American International Group
New York
$139K -$1.3K -10 -0.8%
SRC
67
Shufro Rose & Co
New York
$133K
CI
68
Cigna Investments
Connecticut
$116K +$137K +1,048 New
FQ
69
First Quadrant
California
$113K +$133K +1,020 New
MIM
70
MetLife Investment Management
New Jersey
$111K +$131K +1,002 New
PPA
71
Parametric Portfolio Associates
Washington
$111K +$8.86K +68 +7%
JP Morgan Chase
72
JP Morgan Chase
New York
$104K +$3.52K +27 +3%
VOYA Investment Management
73
VOYA Investment Management
Georgia
$103K
Susquehanna International Group
74
Susquehanna International Group
Pennsylvania
$100K +$46.9K +360 +67%
Citadel Advisors
75
Citadel Advisors
Florida
$85K -$54.3K -417 -35%

SRGA Hedge Fund Activity: Q4 2018 in Review

109 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q4 2018, worth a combined $165M — down 18% from $200M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new SRGA positions and 12 closed out — a net gain of 2 holders — while 32 added to existing stakes and 32 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $1.67M. The largest seller was Rutabaga Capital Management, cutting an estimated $3.55M.

  • 109 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q4 2018, up from 107 in Q3 2018.
  • Funds reported $165M of Surgalign Holdings, Inc. Common Stock stock for Q4 2018, down 18% quarter-over-quarter.
  • 14 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q4 2018 and 12 closed out, a net change of +2 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q4 2018 was Russell Investments Group, an estimated $1.67M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q4 2018 was Rutabaga Capital Management, an estimated $3.55M sold.

Based on aggregated 13F filings for Q4 2018.